40
Participants
Start Date
December 31, 2016
Primary Completion Date
November 14, 2024
Study Completion Date
November 14, 2024
Garmin Vivofit device
Participants will be bio-monitored using the Garmin Vivofit mobile wearable device at baseline (at least 1-7 days prior to treatment initiation) and during induction chemotherapy up to completion of 6 cycles. For those patients continuing with ASCT, patients will be bio-monitored up to 90 days post ASCT.
Mobile Health quality of life assessements
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Memorial Sloan Kettering Cancer Center
OTHER